Technical Title: “Development of New B-cell Markers in Salmonids: Evaluation Tools for Cellular Protection and a Rational Design of Vaccines Against Intracellular Pathogens.
Conventional Title: Evaluation of the Immunity Levels Created by Vaccines or Specific Pathogens that Affect Salmon Populations.
- Director: Dr. Kevin Maisey
General Objective (Technical Description):The development of antibodies against salmonid’s B-lymphocyte surface markers.
Description: This project creates biotechnological tools that will allow salmon producers to evaluate the state of fish’s humoral immunity or defenses, activated by the use of vaccines or exposure to certain pathogens.
The techniques developed will allow for a follow-up of the fish’s whole productive process and will yield predictive results of the fish’s defense state, both qualitatively and quantitatively, in a matter of hours.
This project is the only one in the world that allows for the evaluation of the effectivity degree of current vaccines and even the creation of predictive profiles of humoral immunity in aquaculture species.
Status:The project has concrete results and is in the validation process. Products (flow cytometry kits and ELISA tests) may enter the market by mid 2019.
Project Benefits:Obtaining timely information about the immunity levels or defense states in the observed population could lead to considerable economical and environmental benefits to the industry and its environment.
